Prescription drug dispensing limits and patterns.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 16060485)

Published in Manag Care Interface on July 01, 2005

Authors

Kathryn A Phillips1, Su-Ying Liang, Jennifer S Haas, Marilyn Stebbins, Brian K Alldredge

Author Affiliations

1: Health Economics and Health Services Research, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA. kathryn@itsa.ucsf.edu

Articles citing this

Drug dispensing patterns. Manag Care Interface (2005) 0.75

Articles by these authors

De novo mutations in epileptic encephalopathies. Nature (2013) 7.42

Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med (2006) 3.90

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63

Body mass index, provider advice, and target gestational weight gain. Obstet Gynecol (2005) 2.38

Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34

Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25

Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med (2010) 2.24

Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med (2004) 2.21

Association between language proficiency and the quality of primary care among a national sample of insured Latinos. Med Care (2007) 2.21

Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf (2010) 2.03

Trends in colonoscopy for colorectal cancer screening. Med Care (2007) 1.89

Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87

Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70

Elucidating the role of place in health care disparities: the example of racial/ethnic residential segregation. Health Serv Res (2012) 1.55

The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health (2003) 1.53

AHRQ's hospital survey on patient safety culture: psychometric analyses. J Patient Saf (2009) 1.50

The impact of financial incentives on physician productivity in medical groups. Health Serv Res (2002) 1.47

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev (2006) 1.39

Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res (2012) 1.35

Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer (2014) 1.34

Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31

The effect of area HMO market share on cancer screening. Health Serv Res (2004) 1.29

Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care (2002) 1.26

An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med (2009) 1.26

How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21

Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders. J Womens Health (Larchmt) (2005) 1.16

Factors affecting breast cancer risk reduction practices among California physicians. Prev Med (2004) 1.14

Predictors of compliance with the postpartum visit among women living in healthy start project areas. Matern Child Health J (2006) 1.09

Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther (2008) 1.08

A multidisciplinary teamwork training program: the Triad for Optimal Patient Safety (TOPS) experience. J Gen Intern Med (2008) 1.08

Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) (2005) 1.07

Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med (2009) 1.06

Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med (2013) 1.05

Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03

Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res (2008) 1.00

Assessing the effects of race and ethnicity on use of complementary and alternative therapies in the USA. Ethn Health (2005) 0.99

Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med (2014) 0.98

Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care. J Gen Intern Med (2013) 0.98

What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings. J Gen Intern Med (2008) 0.98

Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care (2004) 0.97

Factors affecting participation in a breast cancer risk reduction telephone survey among women from four racial/ethnic groups. Prev Med (2005) 0.96

Use of practice-based research network data to measure neighborhood smoking prevalence. Prev Chronic Dis (2013) 0.96

Disparities in cancer screening in individuals with a family history of breast or colorectal cancer. Cancer (2011) 0.95

Race/ethnicity, socioeconomic status and the health of pregnant women. J Health Psychol (2007) 0.93

Influence of body weight on patients' satisfaction with ambulatory care. J Gen Intern Med (2002) 0.93

Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92

Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med (2010) 0.92

Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90

Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med (2007) 0.89

Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf (2003) 0.89

Association of breastfeeding with maternal depressive symptoms. J Womens Health (Larchmt) (2006) 0.89

Lifestyle behavior counseling for women patients among a sample of California physicians. J Womens Health (Larchmt) (2005) 0.89

Hospital characteristics and racial disparities in hospital mortality from common medical conditions. J Natl Med Assoc (2007) 0.88

Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf (2007) 0.88

Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control (2004) 0.88

Medicare formulary coverage for top-selling biologics. Nat Biotechnol (2009) 0.87

Race and family history assessment for breast cancer. J Gen Intern Med (2005) 0.87

Clinician characteristics and use of novel electronic health record functionality in primary care. J Am Med Inform Assoc (2011) 0.86

Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med (2010) 0.85

Effects of a multicentre teamwork and communication programme on patient outcomes: results from the Triad for Optimal Patient Safety (TOPS) project. BMJ Qual Saf (2011) 0.83

Zonisamide-induced restless legs syndrome. Neurology (2003) 0.83

Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med (2007) 0.83

Out-of-pocket expenditures for oral contraceptives and number of packs per purchase. J Am Med Womens Assoc (2004) 0.82

Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group. J Manag Care Pharm (2007) 0.82

Surveillance after resection for colorectal cancer. Cancer (2012) 0.82

Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care (2011) 0.81

Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract (2011) 0.81

Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat (2011) 0.80

Income Inequities and Medicaid Expansion are Related to Racial and Ethnic Disparities in Delayed or Forgone Care Due to Cost. Med Care (2016) 0.80

Use of annual mammography among older women with ductal carcinoma in situ. J Gen Intern Med (2011) 0.79

Viagra and contraceptives. Health Aff (Millwood) (2003) 0.79

Clinical features of status epilepticus in patients with HIV infection. Neurology (2005) 0.78

Understanding herb and dietary supplement use in patients with epilepsy. Epilepsia (2009) 0.77

Measuring managed care and its environment using national surveys: a review and assessment. Med Care Res Rev (2006) 0.77

Moving health information technology forward. J Gen Intern Med (2008) 0.77

Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel. Breast Cancer Res Treat (2015) 0.76

In reply. JAMA Intern Med (2013) 0.75

Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore) (2017) 0.75

Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns. Am J Manag Care (2017) 0.75

Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care (2004) 0.75

Can I find a doctor? Availability of primary care physicians in the San Francisco Bay Area. J Fam Pract (2003) 0.75